Drug Type Unknown |
Synonyms TD30 EVO2, TD30EVO2 |
Target |
Action inhibitors, antagonists |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors), PPARγ antagonists(Peroxisome proliferator-activated receptor γ antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | IND Application | Israel | 01 Mar 2025 |